Mash Deborah C, Ouyang Qinjie, Pablo John, Basile Margaret, Izenwasser Sari, Lieberman Abraham, Perrin Richard J
Department of Neurology, University of Miami School of Medicine, Miami, Florida 33101, USA.
J Neurosci. 2003 Apr 1;23(7):2564-71. doi: 10.1523/JNEUROSCI.23-07-02564.2003.
Alpha-synuclein is a presynaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease. The native protein is a major component of nigral Lewy bodies in Parkinson's disease, and full-length alpha-synuclein accumulates in Lewy neurites. Here we present evidence that alpha-synuclein levels are elevated in midbrain dopamine (DA) neurons of chronic cocaine abusers. Western blot and immunoautoradiographic studies were conducted on postmortem neuropathological specimens from cocaine users and age-matched drug-free control subjects. The results demonstrated that alpha-synuclein levels in the DA cell groups of the substantia nigra/ventral tegmental complex were elevated threefold in chronic cocaine users compared with normal age-matched subjects. The increased protein levels in chronic cocaine users were accompanied by changes in the expression of alpha-synuclein mRNA in the substantia nigra and ventral tegmental area. Although alpha-synuclein expression is prominent in the hippocampus, there was no increase in protein expression in this brain region. The levels of beta-synuclein, a possible negative regulator of alpha-synuclein, also were not affected by cocaine exposure. Alpha-synuclein protein levels were increased in the ventral tegmental area, but not the substantia nigra, in victims of excited cocaine delirium who experienced paranoia, marked agitation, and hyperthermia before death. The overexpression of alpha-synuclein may occur as a protective response to changes in DA turnover and increased oxidative stress resulting from cocaine abuse. However, the accumulation of alpha-synuclein protein with long-term cocaine abuse may put addicts at increased risk for developing the motor abnormalities of Parkinson's disease.
α-突触核蛋白是一种突触前蛋白,被认为可能是帕金森病发病机制中的致病因素。天然蛋白是帕金森病黑质路易小体的主要成分,全长α-突触核蛋白在路易神经突中积累。在此我们提供证据表明,慢性可卡因滥用者中脑多巴胺(DA)神经元中的α-突触核蛋白水平升高。对可卡因使用者和年龄匹配的无毒品对照受试者的死后神经病理学标本进行了蛋白质印迹和免疫放射自显影研究。结果表明,与正常年龄匹配的受试者相比,慢性可卡因使用者黑质/腹侧被盖复合体DA细胞群中的α-突触核蛋白水平升高了三倍。慢性可卡因使用者中蛋白质水平的增加伴随着黑质和腹侧被盖区α-突触核蛋白mRNA表达的变化。尽管α-突触核蛋白在海马体中表达突出,但该脑区的蛋白质表达没有增加。α-突触核蛋白的可能负调节因子β-突触核蛋白的水平也不受可卡因暴露的影响。在死前经历妄想、明显躁动和体温过高的兴奋型可卡因谵妄受害者中,腹侧被盖区而非黑质中的α-突触核蛋白水平增加。α-突触核蛋白的过度表达可能是对可卡因滥用导致的DA周转变化和氧化应激增加的一种保护反应。然而,长期滥用可卡因导致的α-突触核蛋白积累可能会使成瘾者患帕金森病运动异常的风险增加。